Mineralys Therapeutics, Inc.
MLYS
$42.16
$2.777.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.44% | 1.32% | -16.22% | 3.88% | 19.16% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 50.35% | 39.08% | -42.85% | -64.45% | -17.94% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 5.43% | 2.22% | -17.56% | 0.89% | 18.00% |
|
|
|||||
| Total Current Assets | 5.43% | 2.22% | -17.56% | 0.89% | 18.00% |
| Net Property, Plant & Equipment | -47.62% | -25.49% | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -3.56% | 4.75% | 878.43% | 786.27% | 780.39% |
| Total Assets | 5.41% | 2.22% | -18.17% | -3.35% | 9.37% |
|
|
|||||
| Total Accounts Payable | 85.35% | -91.25% | -20.30% | -44.27% | -22.27% |
| Total Accrued Expenses | -28.78% | -12.92% | 43.38% | 254.02% | 565.42% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -21.92% | -30.30% | 39.73% | 131.27% | 357.50% |
|
|
|||||
| Total Current Liabilities | -21.92% | -30.30% | 39.73% | 131.27% | 357.50% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -21.92% | -30.30% | 39.73% | 131.27% | 357.50% |
|
|
|||||
| Common Stock & APIC | 43.96% | 41.72% | 34.96% | 34.63% | 34.41% |
| Retained Earnings | -96.73% | -120.67% | -142.58% | -152.77% | -154.30% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 8.09% | 4.12% | -20.69% | -10.26% | 1.78% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.09% | 4.12% | -20.69% | -10.26% | 1.78% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 8.09% | 4.12% | -20.69% | -10.26% | 1.78% |
|
|
|||||